G. Dreyer

发表

A symmetric inhibitor binds HIV-1 protease asymmetrically.

A M Hassell, R. DesJarlais, J. Boehm, 1993, Biochemistry.

Sequence-specific cleavage of single-stranded DNA: oligodeoxynucleotide-EDTA X Fe(II).

P. Dervan, G. Dreyer, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Phosphinic acid inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase

R. Mayer, T. Meek, G. Dreyer, 1991 .

Substrate-based inhibitors of HIV-1 protease

G. Dreyer, M. Moore, 1993 .

Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.

A M Hassell, M. Minnich, D. Lambert, 1992, Biochemistry.

Synthetic studies on arene-olefin cycloadditions. ii. total synthesis of (±)-isocomene

G. Dreyer, P. Wender, 1981 .

Synthetic studies on arene-olefin cycloadditions - V. total synthesis of (±)-isoiridomyrmecin.☆

G. Dreyer, P. Wender, 1983 .

Synthetic studies on arene-olefin cycloadditions. 4. Total synthesis of (.+-.)-modhephene

G. Dreyer, P. Wender, 1982 .

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

Brian W. Metcalf, Michael L. Moore, C. Debouck, 1990, Nature.

Total synthesis of (.+-.)-calanolide A, a non-nucleoside inhibitor of HIV-1 reverse transcriptase

M. West, G. Dreyer, B. Chenera, 1993 .

The pseudocalanolides: structure revision of calanolides C and D.

M. Boyd, G. Dreyer, J. Cardellina, 1995, Journal of natural products.

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.

Z. Ni, D. Chen, Z. Yuan, 2000, Biochemistry.

A convenient synthesis of di- and trisubstituted γ-pyrones

G. Dreyer, Yanghui Zhang, Yong Zhang, 1993 .

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.

C. Debouck, J. Strickler, T. Meek, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Effect of a human immunodeficiency virus protease inhibitor on human monocyte function.

J. Laydon, G. Dreyer, P. Bugelski, 1992, AIDS research and human retroviruses.

Peptide substrates and inhibitors of the HIV-1 protease.

C. Debouck, J. Strickler, T. Meek, 1989, Biochemical and biophysical research communications.

α,α-Difluoroketone inhibitors of HMG CoA reductase

G. Dreyer, B. Metcalf, 1988 .

Synthesis of C2-symmetric and pseudosymmetric HIV-1 protease inhibitors from D-arabitol

J. Boehm, G. Dreyer, B. Chenera, 1991 .

Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice.

J. Baldoni, D. Lambert, G. Dreyer, 1996, Antiviral research.

Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.

D. Lambert, G. Dreyer, B. Metcalf, 1993, Antiviral research.

Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells

D. Lambert, D. Bolognesi, T. Meek, 1992, Antimicrobial Agents and Chemotherapy.

Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage

E. Hunter, G. Dreyer, S. Petteway, 1992, Journal of virology.

Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.

C. Debouck, J. Strickler, M. Rosenberg, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Sequence-specific cleavage of single-stranded DNA : Oligodeoxynucleotide-EDTA-Fe ( II ) ( modified nucleosides / DNA probes / oxidative cleavage of DNA )

G. Dreyer, Peter B. DERVANt, 2003 .

Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture

D. Lambert, G. Dreyer, M. Lewis, 1993, Antimicrobial Agents and Chemotherapy.

HIV‐1 Protease as a Potential Target for Anti‐AIDS Therapy

T. Meek, G. Dreyer, GEOFFREY B. DREYER, 1990, Annals of the New York Academy of Sciences.

Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.

M. Minnich, J. Culp, C. Debouck, 1991, Biochemistry.

Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.

C. Debouck, I. Brooks, J. Strickler, 1992, Biochemistry.

Total Synthesis of (.+-.)-Calanolide A, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.

M. West, G. Dreyer, B. Chenera, 1994 .

Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates.

D. Lambert, T. Matthews, G. Dreyer, 1996, AIDS research and human retroviruses.

An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis.

R. DesJarlais, Baoguang Zhao, K. Murthy, 1994, Biochemistry.

Synthetic Inhibitors of HIV‐1 Protease Block Processing of Pr55gag and Pr160gag‐po1 Polyproteins in Infected T Lymphocytes

D. Lambert, T. Matthews, T. Meek, 1990 .